BackGlobeStar Therapeutics Overview

GlobeStar Therapeutics Total Assets

Latest total assets for GSTC: $84K.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$83874.00

Peer trimmed avg / median

Loading

GlobeStar Therapeutics Total Assets History

Loading

GlobeStar Therapeutics vs. peers: Total Assets Comparison

Loading

GlobeStar Therapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

GlobeStar Therapeutics (GSTC) FAQ

As of the most recent data (June 2024), GSTC shows a total assets of $84K. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GSTC's total assets is now $84K (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether GlobeStar Therapeutics is outperforming or lagging.

Tracking GSTC's total assets over time shows whether GlobeStar Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $84K In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total assets page, Stockcircle has GlobeStar Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $84K) with ownership activity and broader fundamentals.

GlobeStar Therapeutics's total assets is $84K; compare it with other Industrials names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.